RNeasy Plus Kits for RNA Isolation

For fast purification total RNA from cells and tissues using gDNA Eliminator columns or plates

Is sustainability important to you?
For an eco-friendlier alternative to the selected product, look no further.

RNeasy Plus Mini Kit (50)

Cat no. / ID.   74134

For 50 minipreps: RNeasy Mini Spin Columns, gDNA Eliminator Spin Columns, Collection Tubes, RNase-Free Water and Buffers
€427.00
Log in To see your account pricing.
Kit
RNeasy Plus Kit
Eco-friendlier kit
Buffers
Column typePlate type
Mini
Micro
96 well
Preparations
50
250
This product contains substances regulated under REACH (EC 1907/2006 Annex XIV). The use of this product in the EU is permitted subject to an exemption (Article 56(3)). Please refer to the REACH notification and the SDS of this product, both of which can be found in the “Resources” section of this page, for more information.
For information on storage and stability, see the relevant kit handbook, instructions for use or instrument user manual under the Resources tab
RNeasy Plus Kits are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.
Is sustainability important to you?
For an eco-friendlier alternative to the selected product, look no further.

Features

  • Efficient gDNA removal with unique gDNA Eliminator columns or plates (no need for DNase)
  • High-quality total RNA in minutes using fast and simple extraction protocols
  • Phenol-free RNA isolation
  • High-throughput processing in 96-well format
  • Ideal for sensitive applications such as real-time RT-PCR and RNA-seq

Product Details

RNeasy Plus Kits are next generation QIAGEN RNA extraction kits, combining high-quality RNA purification with effective gDNA removal with unique gDNA Eliminator columns or plates. Total RNA of high purity and yield is obtained from a wide range of cultured cells and easy-to-lyse tissues. The RNeasy Plus Micro Kit is specially designed for limited amounts of samples and isolates up to 45 µg pure total RNA The RNeasy Plus Mini Kit purifies up to 100 µg total RNA (>200 nt) from a single extraction with efficient gDNA removal. Both kits can be automated on the QIAcube Connect and samples can be conveniently stabilized using RNAprotect Tissue Reagent or Allprotect Tissue Reagent and efficiently disrupted using a TissueRuptor II or TissueLyser II or LT system (available separately). The RNeasy Plus 96 Kit is for high-throughput purification of total RNA from cultured cells grown in 96-well plates. 

Performance

RNA extraction from cells and tissues with RNeasy Plus Micro and Mini Kits allows high, reproducible RNA yields and efficient genomic DNA elimination for sensitive applications (see figures “ Effective cell genomic DNA removal”, “ Effective tissue genomic DNA removal”, " High, reproducible RNA yields", and “ Array-ready RNA”). Total RNA with Agilent RIN values of close to 10 is routinely obtained from tissues and cultured cells.

RNeasy Plus Micro and Mini Kits also provide an enrichment for mRNA since most RNAs <200 nucleotides (such as rRNAs and tRNAs) are excluded. For isolation of total RNA containing small RNAs (e.g., miRNA) from cultured cells, additional RNA isolation protocols are available and described in the RNeasy Plus Micro Handbook and as a separate Supplementary Protocol to the RNeasy Plus Mini Kit.
The RNeasy Plus 96 Kit is compatible with a wide range of cell lines, providing purification of high-quality RNA with Agilent RIN values of close to 10 (see figure " High-quality RNA"). Complete genomic DNA removal by the kit (see figure "Effective genomic DNA removal") enables specific transcript detection in highly sensitive applications, such as quantitative, real-time RT-PCR analysis of low-abundance targets. In addition, reliable RNA purification from 102 to 106 cells allows real-time RT-PCR quantification over a wide dynamic range (see figure " Reliable RNA purification").

See figures

Principle

The RNeasy Plus procedure integrates QIAGEN’s innovative technology for selective binding of double-stranded DNA with well-established RNeasy technology. Efficient purification of high-quality RNA is guaranteed, without the need for additional DNase digestion. The purified RNA is ready to use and is ideally suited for downstream applications that are sensitive to low amounts of DNA contamination, such as quantitative, real-time RT-PCR.

Cells and easy-to-lyse tissues are first lysed and homogenized in highly denaturing guanidine-isothiocyanate–containing Buffer RLT Plus, which immediately inactivates RNases to ensure isolation of intact RNA. The lysate is then passed through a gDNA Eliminator spin column or gDNA Eliminator 96 plate that, in combination with the high-salt buffer, selectively and efficiently removes genomic DNA. Ethanol is added to provide appropriate binding conditions for RNA, and the sample is applied to an RNeasy spin column or 96-well plate. These specialized columns and 96-well plates contain a silica membrane that specifically binds RNA from lysed cells.
For fatty and difficult-to-lyse tissues, RNeasy Plus Universal Kits are recommended. For isolation of total RNA including miRNA from other sample types, we recommend miRNeasy Kits.

The QIAwave RNA Plus Mini Kit is an eco-friendlier version of our standard RNeasy Plus Mini Kit. Reducing plastic and cardboard usage by up to 47% and 42%, respectively, this version incorporates waste tubes made from 100% post-consumer recycled plastic that can be reused during the procedure. The QIAwave buffers are provided as concentrates, decreasing plastic use by up to 90% per bottle. Despite the visual differences, the QIAwave Kit remains user-friendly, with chemistry and performance identical to the standard kit's.

In partnership with My Green Lab, we've also assessed the environmental impact of the RNeasy Plus Mini Kit (50/250) and the QIAwave RNA Plus Mini Kit (50/250). My Green Lab ACT (accountability, consistency, and transparency) environmental impact factor labels are designed to evaluate and score products on several sustainability criteria. These include: 

  • Manufacturing
  • Responsible chemical management 
  • Sustainable content within products and packaging materials 
  • Disposal of the packaging at the end of life

Products are scored from 1 to 10 except for energy and water consumption, which are scored as 1 point per kWh or gallon, respectively. A low score means a lower environmental impact (see figures "RNA Plus Mini Kits ACT environmental impact factor label  US (  50/  250),  EU (  50/  250) and UK (  50/  250)."

 

See figures

Procedure

The RNeasy Plus Micro Kit purifies total RNA from up to 5 x 105 cells or 5 mg tissue, and the RNeasy Plus Mini Kit isolates total RNA from up to107 cells or 30 mg tissue. A short workflow enables RNA isolation with genomic DNA removal in less than 25 minutes (see flowchart  RNeasy Plus procedure). Samples are first lysed and homogenized. The lysate is passed through a gDNA Eliminator spin column, ethanol is added to the flow-through, and the sample is applied to an RNeasy spin column. RNA binds to the membrane and contaminants are washed away. High-quality RNA is eluted in as little as 14 µl water using the RNeasy Plus Micro Kit or 30 µl water using the RNeasy Plus Mini Kit.

Different protocols are available for different starting materials. The protocols differ mainly in the lysis and homogenization of the sample. Once the sample is applied to the gDNA Eliminator spin column, the protocols are similar. The procedure provides an enrichment for mRNA since most RNAs <200 nucleotides (such as rRNAs and tRNAs) are excluded.

When disrupting and homogenizing tissues in Buffer RLT Plus (supplied with the RNeasy Plus Mini Kit), excessive foaming may occur. This foaming is substantially reduced by adding Reagent DX (supplied separately) to Buffer RLT Plus before starting disruption and homogenization. Reagent DX has been carefully tested with the kit, and has no effect on A purity or on downstream applications.


High-throughput RNA purification is achieved through the use of RNeasy 96 plates. Prior to application to the RNeasy 96 plate, cell lysates are first passed through a gDNA Eliminator 96 plate, (see figure " RNeasy Plus 96 procedure"). The gDNA Eliminator 96 plates are conveniently processed using a centrifuge (Centrifuge 4-16). RNA purification using RNeasy 96 plates is manual, and comprises 3 simple steps: bind, wash, and elute. The plates are rapidly and conveniently processed using either a centrifuge (Centrifuge 4-16 and Plate Rotor 2 x 96) or a combination of vacuum (QIAvac 96) and centrifuge. Up to 2 x 106 cells can be used as starting material when processing plates using a centrifuge, while up to 1 x 106 cells can be used when processing plates using a vacuum and centrifuge. The procedure provides an enrichment for mRNA since most RNAs <200 nucleotides (such as rRNAs and tRNAs) are excluded. The RNeasy Plus procedure can be modified to allow the purification of total RNA containing small RNAs, such as miRNA, from cultured cells.

RNeasy Plus Mini standard protocols can also be executed using the TRACKMAN Connected system, paired with PIPETMAN M Connected pipettes, both from Gilson. The TRACKMAN Connected system guides researchers through the RNeasy Plus Mini protocols while automatically adjusting the Bluetooth-enabled PIPETMAN M Connected pipette settings. Each step of the protocol execution is recorded to accelerate reporting by generating a comprehensive run report. Download more information.

See figures

Applications

RNA purified using RNeasy Plus Kits is ideally suited for downstream applications that are sensitive to low amounts of DNA contamination, such as RNA-seq and quantitative real-time RT-PCR. The purified RNA can also be used in other applications.

The RNeasy Plus Micro Kit is suitable for small samples, including:

  • Laser-microdissected cryosections
  • Fine-needle aspirates

The ease with which RNA is purified in 96-well format makes the RNeasy Plus 96 Kit well suited for high-throughput gene expression analysis in areas such as:

  • Drug discovery
  • Biomedical research

 

Comparison of RNeasy Plus Kits
Features RNeasy Plus Micro Kit RNeasy Plus Mini Kit RNeasy Plus 96 Kit
Applications

RNA-seq, quantitative real-time RT-PCR, end-point RT-PCR,

Northern dot and slot blotting, microarray analysis

RNA-seq, quantitative real-time RT-PCR, end-point RT-PCR,

Northern dot and slot blotting, microarray analysis

RNA-seq, quantitative real-time RT-PCR, end-point RT-PCR,

Northern dot and slot blotting, microarray analysis

Elution volume 14 µl 30–50 µl 45–140 µl
Format Spin column Spin column 96-well plate
Integrated removal of genomic DNA Yes Yes Yes
Main sample type Tissue, cells Tissue, cells Cultured cells
Processing Manual (centrifugation) Manual (centrifugation) Manual (centrifugation, vacuum)

RNA type

Total RNA (> 200 nt) Total RNA (> 200 nt) Total RNA (> 200 nt)
Sample amount 5 x 105 cells or 5 mg tissue 107 cells or 30 mg tissue 10 to 5 x 105 cells
Technology Silica technology Silica technology Silica technology
Time per run or per prep 25 minutes 25 minutes
Yield Varies Varies 1.3–3.1 µg (from 1 x 105 cells)

Supporting data and figures

Resources

Safety Data Sheets (3)
Download Safety Data Sheets for QIAGEN product components.
Download Safety Data Sheets for QIAGEN product components.
Kit Handbooks (3)
Quick-Start Protocols (3)
Scientific Posters (1)
Poster for download
Supplementary Protocols (4)
There are two protocols: follow Protocol 1 if you want to purify total RNA containing miRNA, or follow Protocol 2 if you want to purify small RNA (includes miRNA, 5S rRNA, and tRNA) and larger RNA (>200 nt) separately.
Technical Information (1)
Gene Expression Analysis (1)
Certificates of Analysis (1)

Publications

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.
Bender MJ; McPherson AC; Phelps CM; Pandey SP; Laughlin CR; Shapira JH; Medina Sanchez L; Rana M; Richie TG; Mims TS; Gocher-Demske AM; Cervantes-Barragan L; Mullett SJ; Gelhaus SL; Bruno TC; Cannon N; McCulloch JA; Vignali DAA; Hinterleitner R; Joglekar AV; Pierre JF; Lee STM; Davar D; Zarour HM; Meisel M;
Cell; 2023; 186 (9):1846-1862.e26 2023 Apr 6 PMID:37028428
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.
Chen B; Scurrah CR; McKinley ET; Simmons AJ; Ramirez-Solano MA; Zhu X; Markham NO; Heiser CN; Vega PN; Rolong A; Kim H; Sheng Q; Drewes JL; Zhou Y; Southard-Smith AN; Xu Y; Ro J; Jones AL; Revetta F; Berry LD; Niitsu H; Islam M; Pelka K; Hofree M; Chen JH; Sarkizova S; Ng K; Giannakis M; Boland GM; Aguirre AJ; Anderson AC; Rozenblatt-Rosen O; Regev A; Hacohen N; Kawasaki K; Sato T; Goettel JA; Grady WM; Zheng W; Washington MK; Cai Q; Sears CL; Goldenring JR; Franklin JL; Su T; Huh WJ; Vandekar S; Roland JT; Liu Q; Coffey RJ; Shrubsole MJ; Lau KS;
Cell; 2021; 184 (26):6262-6280.e26 2021 Dec 14 PMID:34910928
TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate.
García-Prat L; Kaufmann KB; Schneiter F; Voisin V; Murison A; Chen J; Chan-Seng-Yue M; Gan OI; McLeod JL; Smith SA; Shoong MC; Parris D; Pan K; Zeng AGX; Krivdova G; Gupta K; Takayanagi SI; Wagenblast E; Wang W; Lupien M; Schroeder T; Xie SZ; Dick JE;
Cell Stem Cell; 2021; 28 (10):1838-1850.e10 2021 Aug 2 PMID:34343492
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion.
Murray ER; Menezes S; Henry JC; Williams JL; Alba-Castellón L; Baskaran P; Quétier I; Desai A; Marshall JJT; Rosewell I; Tatari M; Rajeeve V; Khan F; Wang J; Kotantaki P; Tyler EJ; Singh N; Reader CS; Carter EP; Hodivala-Dilke K; Grose RP; Kocher HM; Gavara N; Pearce O; Cutillas P; Marshall JF; Cameron AJM;
Cell Rep; 2022; 38 (4):110227 2022 Jan 25 PMID:35081338
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo.
Anastasiadou E; Seto AG; Beatty X; Hermreck M; Gilles ME; Stroopinsky D; Pinter-Brown LC; Pestano L; Marchese C; Avigan D; Trivedi P; Escolar DM; Jackson AL; Slack FJ;
Clin Cancer Res; 2020; 27 (4):1139-1149 2020 Nov 18 PMID:33208342